Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MLYS)

Q: What does CUSIP 603170101 represent in this 13F holders report?

CUSIP 603170101 is the security identifier for MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q3 2025?

191 institutional investors reported MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: 603170101

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 79,306,949
Total 13F value: $3,007,317,130
Share change: +12,998,954
Put/Call ratio: 974%
SEC-reported price per share: $37.92
Number of holders: 191
Value change: +$505,416,563
Number of buys: 109
Number of sells: 78
Shares outstanding: 79,235,030

Security key

603170101

Report period

Q3 2025

Institutions

191

Top holders

MLYS full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 Mineralys Therapeutics, Inc. SEC filings Mineralys Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 603170101

Newer quarter: Q4 2025 Previous quarter: Q2 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of MLYS - Mineralys Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

Catalys Pacific, LLC

Comparable rows

15/15

Latest evidence

04 Sep 2025

13D/G 13F Lead comparable stake: 9.9% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 9.9%

Samsara BioCapital, L.P. 8.2%

Andera Partners 4.2%

ADAMS STREET PARTNERS LLC 2.3%

Catalys Pacific, LLC 11%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13D/G 13F Company 13D/G 13F	9.9%	$104,939,988 7,796,433 shares	+$20,308,933	04 Sep 2025
Samsara BioCapital, L.P.	13D/G Srinivas Akkaraju 13D/G	8.2%	$85,419,771 6,346,194 shares	+$8,209,106	04 Sep 2025
Andera Partners	13D/G 13D/G	4.2%	$39,747,075 2,765,976 shares	$0	30 Jun 2025
ADAMS STREET PARTNERS LLC	13D/G 13D/G	2.3%	$15,320,183 1,129,807 shares	$0	31 Dec 2024
Catalys Pacific, LLC	13F Company 13F	11%	$120,468,928 8,903,838 shares	—	30 Jun 2025
Samsara BioCapital, LLC	13F Company 13F	7.2%	$76,781,613 5,674,916 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

191

79,306,949

Rows available

191

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

164

Q3 2025 holders

191

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend